MTRR polymorphism and the risk for colorectal and breast cancer in Romanian patients - A preliminary study

Chirurgia (Romania)

Volumn 107, Issue 3, 2010, Pages 379-382

  Burcos T ^a   Toma, M ^b   Stavarachi, M ^b   Cimponeriu, D ^b   Apostol, P ^b   Popa, E ^a   Stanilescu S ^a   Popa, I ^a   Radu, I ^b   Serafinceanu, C ^d   Panduru, N ^d   Belusica L ^c   Gavrila L ^c  

^a ENT Clinic Coltea Hospital   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c CANTACUZINO INSTITUTE   (Romania)

^d Nutrition and Metabolic Diseases 'N Paulescu'   (Romania)

Author keywords

Breast cancer; Colorectal cancer; MTRR polymorphism; PCR RFLP

Indexed keywords

FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; METHIONINE SYNTHASE REDUCTASE;

AGED; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; COLORECTAL TUMOR; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; ROMANIA;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK ASSESSMENT; RISK FACTORS; ROMANIA;

EID: 84874077718     PISSN: 12219118     EISSN: 1842368X     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Duthie SJ. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull. 1999;55(3):578-92.
2. Su LJ, Arab L. Nutritional status of folate and colon cancer risk: evidence from NHANES I epidemiologic follow-up study. Ann Epidemiol. 2001;11(1):65-72.
3. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, et al. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001;12(4):420-8.
4. Storch KJ, Wagner DA, Burke JF, Young VR. [1-13C; methyl-2H3] methionine kinetics in humans: methionine conservation and cystine sparing. Am J Physiol. 1990;258(5 Pt 1):E790-8.
5. O'Leary VB, Parle-McDermott A, Molloy AM, Kirke PN, Johnson Z, Conley M, et al. MTRR and MTHFR polymorphism: link to Down syndrome? Am J Med Genet. 2002;107(2):151-5.
6. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry. 2002; 41(45):13378-85.
7. Gaughan DJ, Kluijtmans LA, Barbaux S, McMaster D, Young IS, Yarnell JW, et al.The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157(2):451-6.
8. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, et al. Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant. J. Nutr. 2004;134(11):2985-90.
9. Botto N, Andreassi MG, Manfredi S, Masetti S, Cocci F, Colombo MG, et al. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet. 2003;11(9):671-8.
10. Feix A, Winkelmayer WC, Eberle C, Sunder-Plassmann G, Födinger M. Methionine synthase reductase MTRR 66A > G has no effect on total homocysteine, folate, and Vitamin B12 concentrations in renal transplant patients. Atherosclerosis. 2004;174(1):43-8.
11. Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM. Colorectal cancer and the methylenetetrahydrofolate reductase 677C-> T and methionine synthase 2756A-> G polymorphisms: a study of 2,168 case-control pairs from the JANUS cohort. Cancer Epidemiol Biomarkers Prev. 2004;13(12):2175-80.
12. Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter DJ, Chen J, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 1999;8(9):825-9.
13. Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML, et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev. 2004;13(5):787-94.
14. Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Taji H, et al. Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma. Am J Hematol. 2004;77(4):351-7.
15. Skibola CF, Forrest MS, Coppedé F, Agana L, Hubbard A, Smith MT, et al. Polymorphisms and haplotypes in folatemetabolizing genes and risk of non-Hodgkin lymphoma. Blood. 2004;104(7):2155-62. Epub 2004 Jun 15. Comment in: Blood. 2005;105(2):906-7.
16. Kang S, Kim JW, Kang GH, Park NH, Song YS, Kang SB, et al. Polymorphism in folate-and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol. 2005;96(1):173-80.
17. Shrubsole MJ, Gao YT, Cai Q, Shu XO, Dai Q, Jin F, Zheng W. MTR and MTRR polymorphisms, dietary intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006; 15(3):586-8.
18. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab. 1999;67(4):317-23.
19. Uitenbroek DG. Binomial. SISA. 1997 (http://www.quantitativeskills. com/sisa/distributions/binomial.htm); (Accessed 10 .01 .2 010) .
20. http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl; (Accessed 10.01.2010).
21. Steck SE, Keku T, Butler LM, Galanko J, Massa B, Millikan RC, et al. Polymorphisms in methionine synthase, methionine synthase reductase and serine hydroxymethyltransferase, folate and alcohol intake, and colon cancer risk. J Nutrigenet Nutrigenomics. 2008;1(4):196-204. Epub 2008 Jun 2.
22. Theodoratou E, Farrington SM, Tenesa A, McNeill G, Cetnarskyj R, Barnetson RA, et al. Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(1):171-82.
23. Stevens VL, McCullough ML, Pavluck AL, Talbot JT, Feigelson HS, Thun MJ, et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2007; 16(6):1140-7.
24. Xu X, Gammon MD, Zhang H, Wetmur JG, Rao M, Teitelbaum SL, et al. Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. Carcinogenesis. 2007;28(7):1504-9. Epub 2007 Mar 19.
25. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis. 2008; 29(2):356-62. Epub 2008 Jan 3.
26. Matsuo K, Hamajima N, Hirai T, Kato T, Inoue M, Takezaki T, et al. Methionine Synthase Reductase Gene A66G Polymorphism is Associated with Risk of Colorectal Cancer. Asian Pac J Cancer Prev. 2002;3(4):353-359.
27. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control. 2002;13(3):239-48.